Cytek Biosciences Inc (CTKB) Stock Price, Quote & News

Company Profile

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cyt...

Industry: Medical Devices

Sector: Healthcare

Phone: 877 922 9835

Website: cytekbio.com

Address:

47215 Lakeview Blvd, Fremont, United States

OfficialStocktwitsUser May. 8 at 3:49 AM

$CTKB RSI: 60.54, MACD: 0.0790 Vol: 0.16, MA20: 4.61, MA50: 4.49 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

StocktwitsEarnings May. 7 at 8:20 PM

$CTKB Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.15 down -66.67% YoY • Reported revenue of $44.13M up 6.46% YoY • Cytek Biosciences reaffirms its 2026 revenue guidance in the range of $205M to $212M, representing 2% to 5% growth over full year 2025, assuming no currency exchange rate changes.

0 · Reply

SuperGreenToday May. 7 at 2:48 PM

$CTKB Share Price: $4.93 Contract Selected: Oct 16, 2026 $5 Calls Buy Zone: $0.46 – $0.57 Target Zone: $0.74 – $0.90 Potential Upside: 52% ROI Time to Expiration: 161 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

TylerDurd3n Apr. 7 at 10:03 PM

$CTKB

0 · Reply

FormerDemocrat Mar. 16 at 8:13 PM

$CTKB mara

0 · Reply

StocktwitsEarnings Feb. 26 at 9:32 PM

$CTKB Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.34 down -585.71% YoY • Reported revenue of $62.14M up 8.12% YoY • Cytek Biosciences initiates its 2026 revenue guidance for full year 2026 revenue to be in the range of $205M to $212M, representing growth of 2% to 5% over full year 2025.

0 · Reply

OfficialStocktwitsUser Feb. 26 at 3:17 AM

$CTKB RSI: 28.12, MACD: -0.2135 Vol: 0.34, MA20: 4.55, MA50: 4.95 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

RhoRevolution Feb. 4 at 3:51 PM

$CTKB is a medical device company (Cytek Biosciences) providing cell analysis systems; its growth is tied to research funding in immunology and cell biology.

0 · Reply

BillionerOfKing Feb. 3 at 6:06 PM

$CTKB Current Stock Price: $5.02 Contracts to trade: $5.0 CTKB Feb 20 2026 Call Entry: $1.82 Exit: $3.36 ROI: 85% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

SuperGreenToday Jan. 22 at 5:30 PM

$CTKB Share Price: $5.70 Contract Selected: Jul 17, 2026 $5 Calls Buy Zone: $1.47 – $1.81 Target Zone: $2.51 – $3.06 Potential Upside: 61% ROI Time to Expiration: 175 Days | Updates via https://fxcapta.com/stockinfo/

1 · Reply

Cytek Biosciences price target lowered to $5.50 from $6 at Morgan Stanley

May 7, 2026, 4:30 PM EDT - 5 days ago

Cytek Biosciences Earnings Call Transcript: Q1 2026

May 7, 2026, 4:05 PM EDT - 5 days ago

Cytek Biosciences Reports First Quarter 2026 Financial Results

Apr 23, 2026, 4:05 PM EDT - 19 days ago

Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

Mar 9, 2026, 5:00 PM EDT - 2 months ago

Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact

Mar 4, 2026, 11:10 AM EST - 2 months ago

Cytek Biosciences Transcript: TD Cowen 46th Annual Health Care Conference

Feb 26, 2026, 4:30 PM EST - 2 months ago

Cytek Biosciences Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:05 PM EST - 2 months ago

Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook

Feb 18, 2026, 4:05 PM EST - 2 months ago

Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference

Feb 12, 2026, 4:05 PM EST - 3 months ago

Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Jan 14, 2026, 8:15 PM EST - 4 months ago

Cytek Biosciences Transcript: 44th Annual J.P. Morgan Healthcare Conference

2026-01-12T10:20:07.000Z - 4 months ago

Cytek Biosciences reports preliminary Q4 revenue $62M, consensus $56.99M

Jan 12, 2026, 5:00 AM EST - 4 months ago

Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results

2026-01-08T14:43:08.000Z - 4 months ago

Cytek Biosciences price target raised to $5 from $4 at TD Cowen

Dec 3, 2025, 9:00 AM EST - 5 months ago

Cytek Biosciences Transcript: Piper Sandler 37th Annual Healthcare Conference

2025-12-01T21:30:28.000Z - 5 months ago

Cytek Biosciences assumed with an Equal Weight at Morgan Stanley

Nov 12, 2025, 5:00 PM EST - 6 months ago

TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026

2025-11-11T11:35:09.000Z - 6 months ago

Cytek Biosciences price target lowered to $7.50 from $8 at Piper Sandler

Nov 6, 2025, 5:00 PM EST - 6 months ago

Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year

Nov 6, 2025, 4:05 PM EST - 6 months ago

Cytek Biosciences to Participate in Upcoming Investor Conferences

2025-11-05T22:02:37.000Z - 6 months ago

Cytek Biosciences backs FY25 revenue view $196M-$205M, consensus $195.95M

2025-11-05T21:55:40.000Z - 6 months ago

Cytek Biosciences reports Q3 EPS (4c), consensus 1c

Nov 5, 2025, 4:30 PM EST - 6 months ago

Cytek Biosciences Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:05 PM EST - 6 months ago

Cytek Biosciences Reports Third Quarter 2025 Financial Results

Oct 29, 2025, 5:00 PM EDT - 6 months ago

Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry

Oct 22, 2025, 4:05 PM EDT - 7 months ago

Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025

Oct 15, 2025, 5:00 PM EDT - 7 months ago

Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth

Sep 17, 2025, 9:00 AM EDT - 8 months ago

Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q's Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control

Sep 10, 2025, 5:00 PM EDT - 8 months ago

Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA

Sep 10, 2025, 10:00 AM EDT - 8 months ago

Cytek Biosciences Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

2025-08-25T19:25:07.000Z - 9 months ago

Cytek Biosciences management to meet virtually with Piper Sandler

Aug 14, 2025, 11:15 AM EDT - 9 months ago

Cytek Biosciences Transcript: UBS Precision Medicine Frontiers Summit

2025-08-10T20:35:04.000Z - 9 months ago

Cytek Biosciences price target lowered to $4 from $7 at Morgan Stanley

2025-08-06T21:26:06.000Z - 9 months ago

Cytek Biosciences reports Q2 EPS (4c), consensus (1c)

2025-08-06T21:25:32.000Z - 9 months ago

Cytek Biosciences narrows FY25 revenue view to $196M-$200M from $196M-$210M

Aug 6, 2025, 4:30 PM EDT - 9 months ago

Cytek Biosciences Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:05 PM EDT - 9 months ago

Cytek Biosciences Reports Second Quarter 2025 Financial Results

Jun 11, 2025, 2:40 PM EDT - 11 months ago

Cytek Biosciences Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 29, 2025, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

May 28, 2025, 4:05 PM EDT - 1 year ago

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

2025-05-28T12:16:22.000Z - 1 year ago

Cytek Biosciences price target lowered to $7 from $9 at Morgan Stanley

2025-05-16T11:55:09.000Z - 1 year ago

Cytek Biosciences price target lowered to $4 from $6 at Stephens

2025-05-09T10:01:42.000Z - 1 year ago

Cytek Biosciences downgraded to Hold from Buy at TD Cowen

2025-05-08T20:52:14.000Z - 1 year ago

Cytek Biosciences reports Q1 EPS (9c) vs. (5c) last year

2025-05-08T20:50:36.000Z - 1 year ago

Cytek Biosciences cuts FY25 revenue view to $196M-$210M from $204M-$212M

May 8, 2025, 4:30 PM EDT - 1 year ago

Cytek Biosciences Earnings Call Transcript: Q1 2025

May 8, 2025, 4:05 PM EDT - 1 year ago

Cytek Biosciences Reports First Quarter 2025 Financial Results

Apr 29, 2025, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

Apr 24, 2025, 4:05 PM EDT - 1 year ago

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 18, 2025, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

Mar 5, 2025, 10:30 AM EST - 1 year ago

Cytek Biosciences Transcript: TD Cowen 45th Annual Healthcare Conference

2025-03-04T11:38:05.000Z - 1 year ago

Cytek Biosciences price target lowered to $8 from $8.25 at Piper Sandler

2025-02-27T21:55:48.000Z - 1 year ago

Cytek Biosciences reports Q4 revenue $57.48M, consensus $59.38M

2025-02-27T21:55:32.000Z - 1 year ago

Cytek Biosciences sees FY25 revenue $204M-$212M, consensus $216.52M

Feb 27, 2025, 4:30 PM EST - 1 year ago

Cytek Biosciences Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:05 PM EST - 1 year ago

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

Feb 13, 2025, 4:05 PM EST - 1 year ago

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

2025-02-02T10:55:04.000Z - 1 year ago

Cytek Biosciences price target raised to $5.25 from $4.50 at Goldman Sachs

Jan 16, 2025, 11:15 AM EST - 1 year ago

Cytek Biosciences Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 2, 2025, 8:00 AM EST - 1 year ago

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 30, 2024, 8:00 AM EST - 1 year ago

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

Dec 3, 2024, 4:30 PM EST - 1 year ago

Cytek Biosciences Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 1 year ago

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 19, 2024, 5:00 PM EST - 1 year ago

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

Nov 13, 2024, 7:15 PM EST - 1 year ago

Cytek Biosciences Transcript: UBS Global Healthcare Conference 2024

Nov 11, 2024, 11:00 AM EST - 1 year ago

Cytek Biosciences Transcript: Guggenheim Inaugural Global Healthcare Innovation Conference

Nov 7, 2024, 5:00 PM EST - 1 year ago

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

Nov 5, 2024, 4:30 PM EST - 1 year ago

Cytek Biosciences Earnings Call Transcript: Q3 2024

Sep 18, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

Sep 12, 2024, 3:20 PM EDT - 1 year ago

Cytek Announces Resignation of Chief Operating Officer Chris Williams

Sep 6, 2024, 7:45 AM EDT - 1 year ago

Cytek Biosciences Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 21, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

Aug 14, 2024, 5:00 PM EDT - 1 year ago

Cytek Biosciences Transcript: UBS Genomic Medicine Summit

Aug 6, 2024, 4:30 PM EDT - 1 year ago

Cytek Biosciences Earnings Call Transcript: Q2 2024

Jul 30, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

Jun 12, 2024, 9:20 AM EDT - 2 years ago

Cytek Biosciences Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

May 30, 2024, 4:05 PM EDT - 2 years ago

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 5:30 PM EDT - 2 years ago

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

May 20, 2024, 5:30 PM EDT - 2 years ago

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

May 8, 2024, 4:30 PM EDT - 2 years ago

Cytek Biosciences Earnings Call Transcript: Q1 2024

May 8, 2024, 4:05 PM EDT - 2 years ago

Cytek Biosciences Reports First Quarter 2024 Financial Results

Apr 30, 2024, 5:30 PM EDT - 2 years ago

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

Apr 29, 2024, 9:00 AM EDT - 2 years ago

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

Mar 19, 2024, 8:00 AM EDT - 2 years ago

Cytek® Biosciences Names William McCombe Chief Financial Officer

Mar 7, 2024, 5:30 PM EST - 2 years ago

Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions

Mar 6, 2024, 11:10 AM EST - 2 years ago

Cytek Biosciences Transcript: TD Cowen 44th Annual Health Care Conference 2024

Mar 4, 2024, 2:15 PM EST - 2 years ago

Cytek Biosciences Transcript: 45th Annual Raymond James Institutional Investors Conference

Feb 28, 2024, 5:05 PM EST - 2 years ago

Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook

Feb 28, 2024, 5:00 PM EST - 2 years ago

Cytek Biosciences Earnings Call Transcript: Q4 2023

Feb 7, 2024, 4:05 PM EST - 2 years ago

Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Jan 17, 2024, 5:30 PM EST - 2 years ago

Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries

Jan 11, 2024, 11:15 AM EST - 2 years ago

Cytek Biosciences Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Jan 8, 2024, 9:00 AM EST - 2 years ago

Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results

Dec 28, 2023, 4:05 PM EST - 2 years ago

Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 21, 2023, 9:00 AM EST - 2 years ago

Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry

Dec 1, 2023, 7:10 AM EST - 2 years ago

Why these stocks could lose money even if the market gains

AHCO APPS CLFD DDD ENPH HRMY LUMN

Nov 28, 2023, 1:30 PM EST - 2 years ago

Cytek Biosciences Transcript: Piper Sandler 35th Annual Healthcare Conference

Nov 14, 2023, 4:05 PM EST - 2 years ago

Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference

OfficialStocktwitsUser May. 8 at 3:49 AM

0 · Reply

StocktwitsEarnings May. 7 at 8:20 PM

0 · Reply

SuperGreenToday May. 7 at 2:48 PM

0 · Reply

TylerDurd3n Apr. 7 at 10:03 PM

$CTKB

0 · Reply

FormerDemocrat Mar. 16 at 8:13 PM

$CTKB mara

0 · Reply

StocktwitsEarnings Feb. 26 at 9:32 PM

0 · Reply

OfficialStocktwitsUser Feb. 26 at 3:17 AM

0 · Reply

RhoRevolution Feb. 4 at 3:51 PM

$CTKB is a medical device company (Cytek Biosciences) providing cell analysis systems; its growth is tied to research funding in immunology and cell biology.

0 · Reply

BillionerOfKing Feb. 3 at 6:06 PM

0 · Reply

SuperGreenToday Jan. 22 at 5:30 PM

1 · Reply

kubota2323 Jan. 21 at 2:33 PM

$CTKB added/adding

0 · Reply

OfficialStocktwitsUser Jan. 14 at 12:51 AM

$CTKB RSI: 70.27, MACD: 0.1745 Vol: 0.32, MA20: 5.14, MA50: 5.06 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

DARKP00L Jan. 12 at 10:14 AM

$CTKB 05:08 on Jan. 12 2026 Cytek Sees $62M Q4 Revenue, Forecasts About $201M in Full-Year 2025 Sales #tradeideas

0 · Reply

Phoenix2023 Jan. 2 at 4:25 PM

$CTKB Surprised there is not more interest in this company. So few watchers.

1 · Reply

TylerDurd3n Dec. 30 at 9:29 AM

$CTKB Love this thing, waiting for takeoff!

0 · Reply

SigilShares Dec. 25 at 12:30 PM

$CTKB Market behavior suggests investors are rewarding credible delivery more than theoretical upside. Commercial adoption must become steadier to neutralize skepticism around sustainability. If milestones arrive on time, perception can shift faster than fundamentals. Catalysts help, but operating proof ultimately carries the most weight.

0 · Reply

fjtbnh Dec. 18 at 5:39 AM

$CTKB

0 · Reply

SuperGreenToday Dec. 5 at 2:44 PM

$CTKB Share Price: $5.14 Contract Selected: Jul 17, 2026 $5 Calls Buy Zone: $1.95 – $2.41 Target Zone: $3.71 – $4.54 Potential Upside: 80% ROI Time to Expiration: 223 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

TylerDurd3n Nov. 30 at 3:32 AM

$CTKB

0 · Reply

Beepboopscoop Nov. 26 at 2:13 PM

$CTKB People are sleeping on this one.

1 · Reply

Market Cap	532.07M
Revenue (ttm)	201.49M
Net Income (ttm)	-66.54M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-33.02%
Debt to Equity Ratio	0.00

Volume	966,100
Avg Vol	707,770
Day's Range	N/A - N/A
Shares Out	129.14M
Stochastic %K	4%
Beta	1.22
Analysts	Strong Sell
Price Target	$6.00